EUVIMEDEUVIMED entdecken
Crossref

Hsa_circ_0008673 Promotes Breast Cancer Progression by MiR-578/GINS4 Axis

Lu Sun, Shuai Chen, Taiyu Wang, Shisheng Bi

Clinical Breast Cancer · 2023-04 · 23 (3) · 281-290

DOI: 10.1016/j.clbc.2022.12.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2023-04. Verfasst von Lu Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Taizhou Hospital of Traditional Chinese Medicine, Taizhou, China. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMicroRNAsAnimalsHumansFemaleBreastApoptosisCell ProliferationChromosomal Proteins, Non-Histone

Stichwörter der Autor:innen

Breast cancerCell growthGINS4Hsa_circ_0008673miR-578

Substanzen

MicroRNAsGINS4 protein, humanChromosomal Proteins, Non-Histone

Autor:innen und Institutionen

  • Department of Breast Surgery, Taizhou Hospital of Traditional Chinese Medicine, Taizhou, China.
  • Department of Breast Surgery, Taizhou Hospital of Traditional Chinese Medicine, Taizhou, China. Electronic address: biss2007@126.com.

Zitieren

APA

Sun, L., Chen, S., Wang, T., & Bi, S. (2023). Hsa_circ_0008673 Promotes Breast Cancer Progression by MiR-578/GINS4 Axis. Clinical Breast Cancer, 23(3), 281-290. https://doi.org/10.1016/j.clbc.2022.12.015

Vancouver

Sun L, Chen S, Wang T, Bi S. Hsa_circ_0008673 Promotes Breast Cancer Progression by MiR-578/GINS4 Axis. Clinical Breast Cancer. 2023;23(3):281-290. doi:10.1016/j.clbc.2022.12.015

BibTeX
@article{Sun2023,
  author = {Sun, Lu and Chen, Shuai and Wang, Taiyu and Bi, Shisheng},
  title = {Hsa_circ_0008673 Promotes Breast Cancer Progression by MiR-578/GINS4 Axis},
  journal = {Clinical Breast Cancer},
  year = {2023},
  volume = {23},
  number = {3},
  pages = {281--290},
  doi = {10.1016/j.clbc.2022.12.015}
}
Kostenlos starten →